FindTrial
Sign In

Deep Sound Wave Therapy for the prevention of neuropathy in the treatment of colorectal and breast cancer with chemotherapy: a pilot / feasibility study '

Deep Sound Wave Therapy for the prevention of neuropathy in the treatment of colorectal and breast cancer with chemotherapy: a pilot / feasibility study ' - DSWT study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46640
Enrollment
40
Registered
2018-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuropathische aandoening neuropathy neurotoxicity

Interventions

During the CapOX / AC-P treatment, test subjects take place on the DSWT chair instead of on a regular chair and receive specific DSWT treatments in that chair.

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: subjects who will start adjuvant chemotherapy in the form of CapOx or Paclitaxel. subjects in the age of >18 year

Exclusion criteria

Exclusion criteria: subjects with a pacemaker subjects with a weight greater than 140 kg. subjects previously treated with neurotoxic medication Patients with active rheumatoid arthritis.

Design outcomes

Primary

MeasureTime frame
In order to assess whether neuropathy has developed after the last chemotherapy, the primary endpoint was chosen 3 months after the last treatment. The number of fully / dosed courses, prevention of neuropathy (measured according to current guidelines in the department and measured with the FACT / GOG-NTX-13 questionnaire), use of medication against neuropathy and the experience of patients with DSWT (questionnaire Numerical Rating Scales / open questions are registered—

Secondary

MeasureTime frame
nvt—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)